About Knappschaftskrankenhaus Bottrop
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Knappschaftskrankenhaus Bottrop
During the past decade, Knappschaftskrankenhaus Bottrop conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia
2020-05-14
2020-09-22
Completed
377
Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab.
2020-07-30
2025-08-30
Active, not recruiting
179
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
2020-07-29
2024-11-30
Recruiting
498
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
2020-09-28
2025-06-27
Recruiting
750
A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus
2021-06-25
2025-06-30
Recruiting
210
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
2021-05-04
2034-10-26
Recruiting
1,700
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
2021-08-27
2033-11-21
Recruiting
4,100
Epidemiological Characteristics and Outcomes of Patients Admitted to Kenyan Critical Care Units (EPOK).
2021-01-01
2022-09-01
Recruiting
4,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Knappschaftskrankenhaus Bottrop" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials
sponsored, "Klinikum Arnsberg" with 1 trials sponsored, "Leipzig Heart Institute GmbH" with 1 trials sponsored and "Martin-Luther-Universität Halle-Wittenberg"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Knappschaftskrankenhaus Bottrop"
#1 collaborator was "Boston Scientific Corporation" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Knappschaftskrankenhaus Bottrop
According to Clinical.Site data, the most researched conditions in "Knappschaftskrankenhaus Bottrop" are
"Crohn's Disease" (2 trials), "Atherosclerotic Disease" (1 trials), "Chronic Heart Failure" (1 trials), "Lymphoma" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Knappschaftskrankenhaus Bottrop" in a lesser frequency.
Clinical Trials Intervention Types at Knappschaftskrankenhaus Bottrop
Most popular intervention types in "Knappschaftskrankenhaus Bottrop" are "Drug" (4 trials), "Biological" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Mirikizumab" (2 trials), "5FU/LV, Oxaliplatin, Bevacizumab, Irinotecan" (1 trials), "CRT-D implantation" (1 trials), "CRT-P implantation" (1 trials) and "Oxaliplatin, 5FU/LV, Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Knappschaftskrankenhaus Bottrop
The vast majority of trials in "Knappschaftskrankenhaus Bottrop" are
6 trials for "All" genders.
Clinical Trials Status at Knappschaftskrankenhaus Bottrop
Currently, there are NaN active trials in "Knappschaftskrankenhaus Bottrop".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Knappschaftskrankenhaus Bottrop,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Knappschaftskrankenhaus Bottrop, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".